Klebsiella pneumoniae in respiratory tract infectio
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: J150- Pneumonia due to Klebsiella pneumoniae
- Registration Number
- CTRI/2024/01/062099
- Lead Sponsor
- avya Shetty
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
All adult patients whose respiratory samples will be culture positive for Carbapenem Resistant Klebsiella pneumoniae.
Exclusion Criteria
Pregnant ladies, Children less than 18 years
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie carbapenem resistance in Klebsiella pneumoniae respiratory infections?
How does the observational study CTRI/2024/01/062099 compare carbapenem-resistant Klebsiella pneumoniae outcomes with standard-of-care treatments?
What biomarkers are associated with Klebsiella pneumoniae infection severity and treatment response in respiratory tract infections?
What adverse events are commonly reported in patients with carbapenem-resistant Klebsiella pneumoniae respiratory infections and how are they managed?
What combination therapies or alternative drugs show promise against carbapenem-resistant Klebsiella pneumoniae in respiratory tract infections?